Receive Breaking News updates as they occur
The embattled manufacturer of EpiPens said Thursday it would help extreme allergy sufferers meet the costs of the life-saving devices after a five-fold price hike sparked outrage. Mylan NV, which holds a near-monopoly on the manufacture of the epinephrine injectors, said it would expand existing programs to defray out-of-pocket costs but did not say it would lower prices. After a series of price hikes, a pack of two of the devices sells for more than $600, compared to less than $100 in 2007, when Mylan bought the rights to the technology.
By Helen Murphy and Luis Jaime Acosta TACUEYO, Colombia (Reuters) - Jose Toconas picks at branches hanging in rows from the roof of his marijuana drying house and smells their spiky flower buds. In two days he will strip them from their stems, trim the dark green florets into neat little balls and hand them over to dealers working with Marxist rebels of the Revolutionary Armed Forces of Colombia (FARC). "This doesn't make me a drug dealer.